Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OGSIVEO safely and effectively. See full prescribing information for OGSIVEO. OGSIVEO ® (nirogacestat) tablets, for oral use Initial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
OGSIVEO is indicated for adult patients with progressing desmoid tumors who require systemic treatment.
- generic_name
- nirogacestat
- product_names
- nirogacestat
- ndc
- 82448-050, 82448-050-18, 82448-100, 82448-100-14, 82448-150, 82448-150-14
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en